Completed PHASE4 INTERVENTIONAL 2-arm NCT00624013

Treatment of Diabetes and Depression in Hispanics and African Americans and Its Effect on A1c and Quality of Life.

Effect of Pharmacological Treatment of Depression on A1C and Quality of Life in Underserved Hispanics and African Americans With Diabetes: A Randomized, Placebo Controlled Trial.

Sponsor: Charles Drew University of Medicine and Science

Conditions Depression Diabetes

Interventions Placebo sertraline

Updated 8 times since 2017 Last updated: Nov 9, 2017 Started: Sep 30, 2006 Primary completion: Oct 31, 2008 Completion: Oct 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Depression and Diabetes, this trial is completed. The trial is conducted by Charles Drew University of Medicine and Science and has accumulated 8 data snapshots since 2006. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Dec 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Jan 2017 — Dec 2017 [monthly]

Unknown Status PHASE4

First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Charles Drew University of Medicine and Science

Data source: Charles Drew University of Medicine and Science

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States